Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220019595 220008191 0.99 68 Curative (C) 2018-03-27 2018-03-27 AML16 DA 3+10 N N 220031111 AML16 TRIAL
220019596 220017900 1.69 45.6 Curative (C) 2017-02-09 2017-02-13 IDARUBICIN + TRETINOIN N N 220031113 IDARUBICIN + TRETINOIN
220019597 220008200 0 68.8 Palliative (P) 2017-12-15 2017-12-16 ATG + Busulfan + Fludarabine N N 220031142 ATG + BUSULFAN + FLUDARABINE
220019598 220008210 1.57 65.4 Curative (C) 2016-12-20 2016-12-20 Cyclophosphamide TBI Allograft 2 N 220031213 CYCLOPHOSPHAMIDE
220019599 220014481 1.59 0 Curative (C) null 2018-09-17 CYCLOPHOSPHAMIDE + FLUDARABINE N N 220031249 CYCLOPHOSPHAMIDE + FLUDARABINE
220019600 220008222 1.79 98.4 Curative (C) 2019-04-21 2019-04-22 RUXOLITINIB 02 null 220031250 RUXOLITINIB
220019601 220014482 null 90 Disease modification (D) 2016-12-02 2017-04-20 Idarubicin+Tretinoin Spanish Crse4 null null 220031254 IDARUBICIN + TRETINOIN
220019602 220019830 1.65 65 Curative (C) null 2014-06-09 AML Int Guide ADE 8+3+5 (2) N N 220031258 ADE
220019605 220008235 1.84 68 Curative (C) 2016-01-12 2016-01-17 Methotrexate intrathecal 2 N 220031299 METHOTREXATE INTRATHECAL
220019606 220008240 1.59 80.8 Curative (C) null 2014-12-24 Cyclophosphamide TBI Allograft null null 220031302 CYCLOPHOSPHAMIDE
220019607 220008252 1.92 null Curative (C) 2015-10-01 2015-10-01 FLAG N N 220031392 FLAG
220019609 220008263 1.08 55 null 2017-11-17 2017-12-26 BOSUTINIB null null 220031415 BOSUTINIB
220019610 220008271 1.62 null Curative (C) 2014-06-23 2014-08-25 Cyclophosphamide TBI Allograft 02 N 220031435 CYCLOPHOSPHAMIDE
220019611 220008274 null 49.8 Palliative (P) 2016-01-11 2016-01-11 BOSUTINIB 2 N 220031441 BOSUTINIB
220019612 220008277 1.66 null Curative (C) 2014-12-23 2014-12-26 Cyclophosphamide TBI Allograft N N 220031455 CYCLOPHOSPHAMIDE
220019613 220008281 1.66 75 Curative (C) 2013-12-31 2014-07-25 Methotrexate intrathecal N N 220031479 METHOTREXATE INTRATHECAL
220019614 220014507 1.78 65 Curative (C) 2014-09-26 2014-09-28 RUXOLITINIB 2 N 220031482 RUXOLITINIB
220019615 220008287 null 57 Curative (C) null 2017-09-16 AML Int Guide ADE 8+3+5 (2) N null 220031491 ADE
220019616 220008305 null 86.8 Curative (C) null 2016-04-10 BOSUTINIB null N 220031551 BOSUTINIB
220019617 220008310 null 63.5 Curative (C) 2013-12-26 2013-12-26 Cyclophosphamide+Fludara+TBI Allo N N 220031587 CYCLOPHOSPHAMIDE + FLUDARABINE
220019618 220008318 1.69 88 Curative (C) 2014-08-28 2014-10-04 Triple Intrathecal N N 220031606 TRIPLE INTRATHECAL
220019619 220014520 1.75 113.8 Disease modification (D) 2012-12-01 2013-06-29 Cyclophosphamide+Fludara+TBI Allo N N 220031607 CYCLOPHOSPHAMIDE + FLUDARABINE
220019620 220017933 1.91 null Curative (C) 2019-01-19 2019-01-20 ATG + Busulfan + Fludarabine N N 220031612 ATG + BUSULFAN + FLUDARABINE
220019621 220008327 null 16.4 Curative (C) 2013-08-05 2015-06-29 FLAG 2 N 220031621 FLAG
220019622 220008332 1.79 87.8 Disease modification (D) null 2018-03-20 IDARUBICIN + TRETINOIN 02 N 220031625 IDARUBICIN + TRETINOIN
220019624 220019843 1.77 null Curative (C) 2016-01-02 2016-12-06 AML16 Low Dose Cytarabine N N 220031681 AML16 TRIAL
220019625 220008345 1.8 null Curative (C) 2013-05-16 2013-06-23 ATG + Busulfan + Fludarabine N N 220031687 ATG + BUSULFAN + FLUDARABINE
220019626 220008352 1.58 84 Curative (C) 2017-09-20 2017-09-20 ATG + Busulfan + Fludarabine N N 220031700 ATG + BUSULFAN + FLUDARABINE
220019627 220008354 null 18.3 Disease modification (D) 2016-12-19 2017-04-06 Cyclophosphamide+Fludara+TBI Allo N N 220031720 CYCLOPHOSPHAMIDE + FLUDARABINE
220019628 220017941 1.63 83.45 Not known (9) 2013-11-01 2013-11-08 Idarubicin+Tretinoin Spanish Crse1 N N 220031735 IDARUBICIN + TRETINOIN
220019629 220008362 1.75 null Curative (C) 2014-07-23 2014-07-23 AML16 DA 2+5 2 N 220031736 AML16 TRIAL
220019631 220008364 1.03 29 Curative (C) 2015-04-12 2015-04-12 BOSUTINIB N N 220031746 BOSUTINIB
220019632 220014541 1.72 89.6 Curative (C) null 2014-05-17 BOSUTINIB N null 220031749 BOSUTINIB
220019633 220014542 1.64 54 Palliative (P) 2016-10-06 2016-10-07 BOSUTINIB 2 N 220031774 BOSUTINIB
220019634 220008371 1.49 75 Curative (C) null 2014-08-05 Triple Intrathecal N N 220031784 TRIPLE INTRATHECAL
220019635 220008375 1.6 56 Curative (C) 2013-06-24 2013-06-25 Cyclophosphamide + Fludarabine IV N N 220031792 CYCLOPHOSPHAMIDE + FLUDARABINE
220019636 220008377 1.63 null Disease modification (D) 2016-07-26 2016-07-26 Idarubicin+Tretinoin Spanish Crse2 N N 220031796 IDARUBICIN + TRETINOIN
220019637 220008379 1.65 75.4 Disease modification (D) 2018-10-28 2018-10-28 AML Int Guide ADE 8+3+5 (2) Y null 220031797 ADE
220019639 220008389 1.63 null Curative (C) 2018-10-18 2019-01-13 CYCLOPHOSPHAMIDE + FLUDARABINE N N 220031813 CYCLOPHOSPHAMIDE + FLUDARABINE
220019641 220017949 null 113.8 Curative (C) 2014-02-06 2014-02-10 BOSUTINIB N N 220031821 BOSUTINIB
220019642 220014551 1.85 55.2 Curative (C) 2018-07-14 2018-07-14 BOSUTINIB N N 220031869 BOSUTINIB
220019643 220008400 null 87.5 Curative (C) 2017-02-03 2017-08-07 Methotrexate intrathecal 99 N 220031880 METHOTREXATE INTRATHECAL
220019644 220008403 1.75 65 Curative (C) 2018-07-17 2018-08-31 Cyclophosphamide + Fludarabine IV 02 N 220031895 CYCLOPHOSPHAMIDE + FLUDARABINE
220019645 220008404 null 63.9 null null 2016-01-31 Cyclophosphamide TBI Allograft N null 220031901 CYCLOPHOSPHAMIDE
220019646 220008409 1.56 56.7 Curative (C) 2013-06-30 2013-12-04 Methotrexate intrathecal N N 220031924 METHOTREXATE INTRATHECAL
220019647 220008414 null 15.3 Curative (C) 2016-04-01 2016-04-02 IDARUBICIN + TRETINOIN Y N 220031935 IDARUBICIN + TRETINOIN
220019650 220008418 1.52 77.8 Curative (C) 2016-12-25 2017-03-10 Cyclophosphamide TBI Allograft N N 220031947 CYCLOPHOSPHAMIDE
220019651 220014564 1.65 null null 2014-10-08 2014-10-18 Methotrexate intrathecal N null 220031962 METHOTREXATE INTRATHECAL
220019652 220022105 1.68 74.2 Curative (C) null 2018-01-27 AML Int Guide ADE 8+3+5 (2) 02 N 220031971 ADE
220019653 220008428 1.75 84.6 Curative (C) 2015-12-21 2016-02-06 AML16 DA 3+8 2 N 220031998 AML16 TRIAL